Loading viewer...
earnings
Format: PDF earnings
Novozymes reported 9% organic sales growth for full year 2022 with solid EBIT margins of 26.4% before special items, driven by diversified performance across five business areas including bioenergy, household care, and food & beverages. The company outlined 2023 guidance of 4-7% organic sales growth with expected EBIT margins of 25-26% and announced a proposed combination with Chr. Hansen to create a leading global biosolutions partner.
earnings
16 Pages
DraftKings
TEN Q3 2023 Earnings Presentation | Tsakos Energy Navigation
earningsearnings
16 Pages
Tsakos Energy Navigation
Blackstone Mortgage Trust 2022 Q4 & Full Year Earnings Results
earningsearnings
20 Pages
Blackstone Mortgage Trust